Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: J Hepatol. 2014 Jul 10;61(5):1056–1063. doi: 10.1016/j.jhep.2014.06.038

Table1.

Summary of the demographics, clinical features and genetic alterations of the three probands

Patient
Number
Ethnicity
(Consanguinity)
Age of
Onset
Age at the
time of
transplant
Age of
Death/
Current Age
Presenting
Features
Gene
(NM_number)
Mutation Homozygous /
Heterozygous
Amino Acid or
Nucleotide change
(coding DNA
nomenclature)
1 Indian (Yes) 5 y 9 y 9 y / NA bilateral lower extremities spasms and abnormal LFTs MPV17 (NM_002437.4) Missense Homozygous R50W (c.148T>C)
2 Pakistani (Yes) 2 d NA 12 d / NA shock, coagulopathy, lactic acidemia, hyperammonemia, elevated transaminases, hyperbilirubinemia and hypoalbuminemia SERAC1 (NM_032861.3) Splice site Homozygous IVS13+1OC (c.1403+1G>C)
3 Hispanic (No) 3 m NA NA / 8 y jaundice and pruritus NOTCH2 (NM_024408.3) Missense Compound Heterozygous S1741L (c.5222C>T) and H1882Y (c.5644C>T)

y=years; d=days; m=months; NA=not applicable; LFTs=liver function tests.

HHS Vulnerability Disclosure